Publication:
Hepatitis B and NAFLD: Lives Crossed.

Simple item page
dc.contributor.authorMorales, María L
dc.contributor.authorSendra, Carmen
dc.contributor.authorRomero-Gomez, Manuel
dc.date.accessioned2023-01-25T09:43:37Z
dc.date.available2023-01-25T09:43:37Z
dc.date.issued2017
dc.description.abstractHepatitis B virus infection seems to protect against steatosis and insulin resistance decreasing NAFLD. Metabolic syndrome has been associated with increased risk of disease progression to cirrhosis and liver cancer in hepatitis B. HBsAg seroclearance increased over time and it could be a confounding factor when analysing NAFLD and hepatitis B prevalence.
dc.identifier.doi10.5604/16652681.1231556
dc.identifier.issn1665-2681
dc.identifier.pmid28233740
dc.identifier.unpaywallURLhttps://doi.org/10.5604/16652681.1231556
dc.identifier.urihttp://hdl.handle.net/10668/10900
dc.issue.number2
dc.journal.titleAnnals of hepatology
dc.journal.titleabbreviationAnn Hepatol
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen Macarena
dc.page.number185-187
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectHBeAg
dc.subjectHBsAg
dc.subjectHepatitis B
dc.subjectNAFLD
dc.subjectNASH
dc.subject.meshHepatitis B
dc.subject.meshHepatitis B Surface Antigens
dc.subject.meshHepatitis B virus
dc.subject.meshHepatitis B, Chronic
dc.subject.meshHumans
dc.subject.meshNon-alcoholic Fatty Liver Disease
dc.titleHepatitis B and NAFLD: Lives Crossed.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number16
dspace.entity.typePublication

Files

Collections

Instituto de Investigación Biomédica de Sevilla (IBIS)
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía